SE8803309D0 - Antiviral agents - Google Patents
Antiviral agentsInfo
- Publication number
- SE8803309D0 SE8803309D0 SE8803309A SE8803309A SE8803309D0 SE 8803309 D0 SE8803309 D0 SE 8803309D0 SE 8803309 A SE8803309 A SE 8803309A SE 8803309 A SE8803309 A SE 8803309A SE 8803309 D0 SE8803309 D0 SE 8803309D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- formula
- phosphonate
- salts
- azidomethyl
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- -1 purine nucleoside phosphonate derivatives Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 abstract 2
- 125000004970 halomethyl group Chemical group 0.000 abstract 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical class N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 1
- 229930024421 Adenine Natural products 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 229960000643 adenine Drugs 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 150000005690 diesters Chemical class 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 abstract 1
- 239000002212 purine nucleoside Substances 0.000 abstract 1
- 150000003212 purines Chemical class 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US547187A | 1987-01-20 | 1987-01-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8803309L SE8803309L (sv) | 1988-09-19 |
| SE8803309D0 true SE8803309D0 (sv) | 1988-09-19 |
Family
ID=21716038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8803309A SE8803309D0 (sv) | 1987-01-20 | 1988-09-19 | Antiviral agents |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0309491A1 (enExample) |
| JP (1) | JPH01501864A (enExample) |
| DE (1) | DE3790883T1 (enExample) |
| GB (1) | GB2209338A (enExample) |
| NL (1) | NL8720745A (enExample) |
| SE (1) | SE8803309D0 (enExample) |
| WO (1) | WO1988005438A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0335770B1 (en) * | 1988-04-01 | 1997-01-15 | Merrell Pharmaceuticals Inc. | Novel fluorophosphonate nucleotide derivatives |
| US5208221A (en) * | 1990-11-29 | 1993-05-04 | Bristol-Myers Squibb Company | Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
| AU2641192A (en) * | 1991-09-24 | 1993-04-27 | Wellcome Foundation Limited, The | Therapeutic nucleosides |
| US5532225A (en) * | 1992-07-31 | 1996-07-02 | Sri International | Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods |
| JPH09506333A (ja) * | 1993-09-17 | 1997-06-24 | ギリアード サイエンシーズ，インコーポレイテッド | 治療化合物の投薬方法 |
| US5798340A (en) | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
| US5717095A (en) * | 1995-12-29 | 1998-02-10 | Gilead Sciences, Inc. | Nucleotide analogs |
| US5877166A (en) * | 1996-04-29 | 1999-03-02 | Sri International | Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents |
| US5922695A (en) * | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
| US20040224917A1 (en) | 2003-01-14 | 2004-11-11 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0273169A3 (en) * | 1983-05-24 | 1990-08-29 | Sri International | Novel antiviral agents |
| CA1288098C (en) * | 1984-08-24 | 1991-08-27 | Richard L. Tolman | 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity |
-
1987
- 1987-12-23 JP JP63501095A patent/JPH01501864A/ja active Pending
- 1987-12-23 EP EP88900934A patent/EP0309491A1/en not_active Withdrawn
- 1987-12-23 DE DE19873790883 patent/DE3790883T1/de not_active Withdrawn
- 1987-12-23 WO PCT/US1987/003446 patent/WO1988005438A1/en not_active Ceased
- 1987-12-23 NL NL8720745A patent/NL8720745A/nl not_active Application Discontinuation
-
1988
- 1988-09-12 GB GB8821380A patent/GB2209338A/en active Pending
- 1988-09-19 SE SE8803309A patent/SE8803309D0/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NL8720745A (nl) | 1988-12-01 |
| SE8803309L (sv) | 1988-09-19 |
| WO1988005438A1 (en) | 1988-07-28 |
| EP0309491A1 (en) | 1989-04-05 |
| JPH01501864A (ja) | 1989-06-29 |
| DE3790883T1 (enExample) | 1988-12-08 |
| GB2209338A (en) | 1989-05-10 |
| GB8821380D0 (en) | 1988-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8803309D0 (sv) | Antiviral agents | |
| PA8483101A1 (es) | Compuestos quimicos | |
| KR900701817A (ko) | 뉴클레오사이드 유도체와 그의 제조방법 | |
| KR900004735A (ko) | 시클로부탄 유도체 및 그 제조방법 | |
| DK0513917T4 (da) | Antivirale kombinationer indeholdende nukleosidanaloger | |
| NZ228645A (en) | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections | |
| DK0545966T3 (da) | Phospholipidderivater af nucleosider, deres fremstilling samt deres anvendelse som anti-virale lægemidler | |
| ATE133678T1 (de) | 9-purinyl-phosphonsäurederivate | |
| SE7509675L (sv) | Forfarande for framstellning av purinforeningar och salter derav | |
| SE8801406D0 (sv) | Medel mot retrovirala infektioner | |
| KR920002623A (ko) | 특정 뉴클레오사이드의 카보사이클릭 동족체 | |
| FI20001231L (fi) | 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina | |
| ES2117134T3 (es) | Analogos de 1,5-anhidrohexitol-nucleosidos y su uso farmaceutico. | |
| DK0481754T3 (da) | Hydroxymethyl (methylencyclopentyl) puriner og -pyrimidiner. | |
| KR930006036A (ko) | 퓨린 및 피리미딘의 불포화 비환식 포스포네이트 유도체 | |
| NL300247I2 (nl) | 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten. | |
| KR880013937A (ko) | 옥세타노신 유도체 | |
| KR870006900A (ko) | 항바이러스 조성물 | |
| DE69320945D1 (de) | Antivirale nukleosidanaloge | |
| DK615788A (da) | Nucleosidforbindelser til anvendelse mod virale infektioner | |
| SE7702231L (sv) | Sett att framstella en substituerad purin | |
| HU913502D0 (en) | Process for the production of medical prepartions for fighting human retrovirus, containing xantine derivatives as active agents | |
| DE69110528D1 (de) | Chirale 2-(Phosphonomethoxy)propyl-Guanine als antivirale Agentien. | |
| DE68918036D1 (de) | Nukleosid-Derivate. | |
| KR960704464A (ko) | 포유동물 세포에서의 뉴클레오사이드와 뉴클레오베이스 수송억제 방법 및 바이러스 복제억제 방법(method for inhibiting nucleoside and nucleoside transport and virus replication in mammalian cells) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8803309-7 Effective date: 19930701 |